Search Results - "BARRIERE, S. L"

Refine Results
  1. 1

    Telavancin Pharmacokinetics and Pharmacodynamics in Patients with Complicated Skin and Skin Structure Infections and Various Degrees of Renal Function by LODISE, T. P, BUTTERFIELD, J. M, HEGDE, S. S, SAMARA, E, BARRIERE, S. L

    Published in Antimicrobial Agents and Chemotherapy (01-04-2012)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Effects of telavancin on coagulation test results by Barriere, S L, Goldberg, M R, Janc, J W, Higgins, D L, Macy, P A, Adcock, D M

    “…The lipoglycopeptide antibiotic, telavancin, may interfere with some laboratory coagulation tests including prothrombin time (PT) and activated partial…”
    Get more information
    Journal Article
  4. 4

    An overview of mortality risk prediction in sepsis by Barriere, Steven L, Lowry, Stephen F

    Published in Critical care medicine (01-02-1995)
    “…OBJECTIVE To review the evolution and development of mortality risk prediction methods as they have been applied to the management of septic patients. DATA…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Analysis of Phase 3 telavancin nosocomial pneumonia data excluding patients with severe renal impairment and acute renal failure by Torres, A., Rubinstein, E., Corey, G. R., Stryjewski, M. E., Barriere, S. L.

    Published in Journal of antimicrobial chemotherapy (01-04-2014)
    “…Objectives Telavancin is approved in Europe for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus when other…”
    Get full text
    Journal Article
  7. 7

    Ciprofloxacin and rifampin, alone and in combination, for therapy of experimental Staphylococcus aureus endocarditis by KAATZ, G. W, SEO, S. M, BARRIERE, S. L, ALBRECHT, L. M, RYBAK, M. J

    Published in Antimicrobial Agents and Chemotherapy (01-08-1989)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  8. 8

    Pharmacokinetic disposition and bactericidal activities of cefepime, ceftazidime, and cefoperazone in serum and blister fluid by KALMAN, D, BARRIERE, S. L, LAMAR JOHNSON, B. JR

    Published in Antimicrobial Agents and Chemotherapy (01-02-1992)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  9. 9

    Serum and blister fluid pharmacokinetics and bactericidal activities of ampicillin-sulbactam, cefotetan, cefoxitin, ceftizoxime, and ticarcillin-clavulanate by JARESKO, G. S, BARRIERE, S. L, JOHNSON, B. L

    Published in Antimicrobial Agents and Chemotherapy (01-10-1992)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  10. 10

    Effect of protein binding on serum bactericidal activities of ceftazidime and cefoperazone in healthy volunteers by LAM, Y. W. F, DUROUX, M. H, GAMBERTOGLIO, J. G, BARRIERE, S. L, GUGLIELMO, B. J

    Published in Antimicrobial Agents and Chemotherapy (01-03-1988)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  11. 11

    Development of resistance to fleroxacin during therapy of experimental methicillin-susceptible Staphylococcus aureus endocarditis by KAATZ, G. W, SEO, S. M, BARRIERE, S. L, ALBRECHT, L. M, RYBAK, M. J

    Published in Antimicrobial Agents and Chemotherapy (01-08-1991)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  12. 12

    Ciprofloxacin-resistant Haemophilus influenzae infection in a patient with chronic lung disease by Barriere, S L, Hindler, J A

    Published in The Annals of pharmacotherapy (01-03-1993)
    “…To report a case of ciprofloxacin-resistant Haemophilus influenzae infection in a patient with chronic lung disease who was exposed to multiple courses of…”
    Get more information
    Journal Article
  13. 13

    Review of the pharmacology, pharmacokinetics, and clinical use of cephalosporins by KALMAN, D, BARRIERE, S. L

    Published in Texas Heart Institute journal (1990)
    “…The cephalosporins have emerged as one of the most widely prescribed classes of antibiotics in the United States. The tremendous growth of this group of drugs…”
    Get full text
    Journal Article
  14. 14

    Efficacy of ofloxacin in experimental Staphylococcus aureus endocarditis by KAATZ, G. W, SEO, S. M, BARRIERE, S. L, ALBRECHT, L. M, RYBAK, M. J

    Published in Antimicrobial Agents and Chemotherapy (01-02-1990)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  15. 15

    Ciprofloxacin versus vancomycin in the therapy of experimental methicillin-resistant Staphylococcus aureus endocarditis by KAATZ, G. W, BARRIERE, S. L, SCHABERG, D. R, FEKETY, R

    Published in Antimicrobial Agents and Chemotherapy (01-04-1987)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  16. 16

    Alteration in the pharmacokinetic disposition of ciprofloxacin by simultaneous administration of azlocillin by BARRIERE, S. L, CATLIN, D. H, ORLANDO, P. L, NOE, A, FROST, R. W

    Published in Antimicrobial Agents and Chemotherapy (01-05-1990)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  17. 17

    Enhanced elimination of ciprofloxacin after multiple-dose administration of rifampin to rabbits by BARRIERE, S. L, KAATZ, G. W, SEO, S. M

    Published in Antimicrobial Agents and Chemotherapy (01-04-1989)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  18. 18

    Bacterial resistance to beta-lactams, and its prevention with combination antimicrobial therapy by Barriere, S L

    Published in Pharmacotherapy (01-01-1992)
    “…The clinical and economic impacts of bacterial resistance are substantial. The development of bacterial resistance during a course of therapy often leads to…”
    Get more information
    Journal Article
  19. 19

    Economic impact of oral ciprofloxacin. A pharmacist's perspective by Barriere, S L

    Published in The American journal of medicine (27-04-1987)
    “…With increasing numbers of patients covered under diagnostic-related group or prospective payment systems, there is mounting pressure to reduce the costs…”
    Get more information
    Journal Article
  20. 20

    Altered pharmacokinetic disposition of ciprofloxacin and vancomycin after single and multiple doses in rabbits by BARRIERE, S. L, KAATZ, G. W, SCHABERG, D. R, FEKETY, R

    Published in Antimicrobial Agents and Chemotherapy (01-07-1987)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article